1280786-59-5 Usage
Uses
Used in Pharmaceutical Industry:
t-Butyl 6-chloro-2-pyridinecarboxylate is used as an intermediate in the production of active pharmaceutical ingredients for its ability to be a building block in the synthesis of various medications.
Used in Agrochemical Industry:
t-Butyl 6-chloro-2-pyridinecarboxylate is used as a precursor in the synthesis of agrochemicals, contributing to the development of effective crop protection products.
It is important to handle this chemical with care, as it may be harmful if ingested, inhaled, or in contact with skin and eyes. Additionally, it should be stored in a cool, dry place away from heat and sources of ignition.
Check Digit Verification of cas no
The CAS Registry Mumber 1280786-59-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,0,7,8 and 6 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1280786-59:
(9*1)+(8*2)+(7*8)+(6*0)+(5*7)+(4*8)+(3*6)+(2*5)+(1*9)=185
185 % 10 = 5
So 1280786-59-5 is a valid CAS Registry Number.
1280786-59-5Relevant academic research and scientific papers
SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRIDINE-3(2H)-ONES AND 2,5,6,7-TETRAHYDRO-3H-PYRROLO[2,1-C][1,2,4]TRIAZOL-3-ONES, AND USE THEREOF
-
Paragraph 0829-0831, (2019/06/12)
The present application relates to novel substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-c][1,2,4]triazol-3-ones, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of lung inflammation disorders.
CXCR4 Receptor Antagonists
-
, (2013/11/06)
Disclosed are compounds that are antagonists of the CXCR4 receptor.
CXCR4 RECEPTOR ANTAGONISTS
-
, (2012/05/04)
The compounds of formula (I) are antagonists of the CXCR4 receptor Wherein R1, X, Y and R2 are as defined in the claims.
